MCA Logo

Curated Literature

All 24 papers curated into MCA, ordered by year of publication. Each entry links to the original record on PubMed.

2026
Clostridioides difficile pathogenesis and control.
Chilton et al., Nature Reviews Microbiology, (2026), PMID 41039149
Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges.
Rogalidou, Frontiers in Pediatrics, (2026), PMID 41641127
2025
Bloodstream infection by Lactobacillus rhamnosus in a haematology patient: why metagenomics can make the difference.
Mannavola et al., Gut Pathogens, (2025), PMID 40544256
2024
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection.
Stallhofer et al., Visceral Medicine, (2024), PMID 38584858
A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Clostridioides difficile Infection.
Wang et al., Antibiotics, (2024), PMID 38786164
Oral Pathobiont-Derived Outer Membrane Vesicles in the Oral–Gut Axis.
Catalan et al., International Journal of Molecular Sciences, (2024), PMID 39456922
2023
Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections.
Schlechte et al., Nature Medicine, (2023), PMID 36894652
2022
Within-host evolution of a gut pathobiont facilitates liver translocation.
Yang et al., Nature, (2022), PMID 35831502
2021
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Baruch et al., Science, (2021), PMID 33303685
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice.
Lee et al., Nature Microbiology, (2021), PMID 33432149
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Davar et al., Science, (2021), PMID 33542131
The microbiome and human cancer.
Sepich-Poore et al., Science, (2021), PMID 33766858
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Spencer et al., Science, (2021), PMID 34941392
2020
Microbiota Insights in Clostridium difficile Infection and Inflammatory Bowel Disease.
Rodríguez et al., Gut Microbes, (2020), PMID 32129694
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.
Kitamoto et al., Cell, (2020), PMID 32758418
2019
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report.
Posteraro et al., Gut Pathogens, (2019), PMID 31548871
2018
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Gopalakrishnan et al., Science, (2018), PMID 29097493
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Routy et al., Science, (2018), PMID 29097494
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Matson et al., Science, (2018), PMID 29302014
c-Maf-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont.
Xu et al., Nature, (2018), PMID 29414937
Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.
Li et al., Clinical Infectious Diseases, (2018), PMID 29546356
Translocation of a gut pathobiont drives autoimmunity in mice and humans.
Manfredo Vieira et al., Science, (2018), PMID 29590047
2015
Gastrointestinal Dissemination and Transmission of Staphylococcus aureus following Bacteremia.
Kernbauer et al., Infection and Immunity, (2015), PMID 25385792
2014
Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile.
Britton et al., Gastroenterology, (2014), PMID 24503131